Detección precoz del cáncer de pulmón

1. Health Quality & Safety Commission New Zealand. Atlas of healthcare variation: Lung cancer. Available from: https://www.hqsc.govt.nz/ our-programmes/health-quality-evaluation/projects/atlas-of-healthcare-variation/lung-cancer/ (Accessed Jan, 2021).

2. Ministry of Health. New cancer registrations 2017. 2019. Available from: https://www.health.govt.nz/publication/new-cancer-registrations-2017 (Accessed Jan, 2021).

3. Ministry of Health. Mortality 2017 data tables. 2019. Available from: https:// www.health.govt.nz/publication/mortality-2017-data-tables (Accessed Jan, 2021).

4. Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. The Lancet Oncology 2019;20:1493–505. doi:10.1016/S1470-2045(19)30456-5

5. Lawrenson R, Lao C, Brown L, et al. Management of patients with early stage lung cancer – why do some patients not receive treatment with curative intent? BMC Cancer 2020;20:109. doi:10.1186/s12885-020-6580-6

6. Lawrenson R, Lao C, Brown L, et al. Characteristics of lung cancers and accuracy and completeness of registration in the New Zealand Cancer Registry. 2018;131:13–23.

7. Office for National Statistics. Cancer survival in England: national estimates for patients followed up to 2017. 2019. Available from: https://www. ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/ conditionsanddiseases/bulletins/cancersurvivalinengland/nationalestima tesforpatientsfollowedupto2017#focus-on-common-cancers-and-survival (Accessed Jan, 2021).

8. National Cancer Institute. Non-small cell lung cancer treatment (PDQ) - health professional version. 2020. Available from: https://www.cancer.gov/types/ lung/hp/non-small-cell-lung-treatment-pdq#link/_478 (Accessed Jan, 2021).

9. National Cancer Institute. Small cell lung cancer treatment (PDQ) - health professional version. 2020. Available from: https://www.cancer.gov/types/ lung/hp/small-cell-lung-treatment-pdq (Accessed Jan, 2021).

10. University of Otago. Media release: Lung cancer screening a step closer to reality following combined study. 2020. Available from: https://www.otago. ac.nz/news/news/otago744523.html (Accessed Jan, 2021).

11. McLeod M, Sandiford P, Kvizhinadze G, et al. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis. BMJ Open 2020;10:e037145. doi:10.1136/ bmjopen-2020-037145

12. Weller DP, Peake MD, Field JK. Presentation of lung cancer in primary care. NPJ Prim Care Respir Med 2019;29:21. doi:10.1038/s41533-019-0133-y

13. Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS ONE 2011;6:e17479. doi:10.1371/journal.pone.0017479

14. Ministry of Health. Faster cancer treatment: High suspicion of cancer definitions. 2016. Available from: https://nsfl.health.govt.nz/system/files/ documents/publications/high_suspicion_of_cancer_definitions_0.pdf (Accessed Jan, 2021).

15. Cancer Australia, Australian Government. Investigating symptoms of lung cancer: a guide for all health professionals. 2020. Available from: https://www.canceraustralia.gov.au/sites/default/files/publications/ investigating-symptoms-lung-cancer-guide-all-health-professionals/pdf/ investigating_symptoms_of_lung_cancer_-_the_guide.pdf (Accessed Jan, 2021).

16. Centers for Disease Control and Prevention. Health effects of secondhand smoke. 2020. Available from: https://www-cdc-gov.ezproxy.otago.ac.nz/ tobacco/data_statistics/fact_sheets/secondhand_smoke/health_effects/index. htm (Accessed Feb, 2021).